GlassScriptPhysician profile
Michelle Zoccolillo
NPI 1699168989
$55,580.35
in general payments reported to CMS, 2019-2025
10 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,288 · 2020: $389 · 2021: $53K · 2022: $469 · 2023: $280 · 2024: $321 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $52,967.61 | 2021-2025 | |
| Stryker Corporation | $2,072.91 | 2019-2023 | Na |
| Geistlich Pharma, North America, INC. | $202.28 | 2024 | Geistlich Bio-Gide |
| Nobel Biocare USA | $125.95 | 2019-2021 | |
| Axogen | $72.14 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Kowa Pharmaceuticals America, INC. | $43.05 | 2023 | Seglentis |
| Depuy Synthes Sales INC. | $31.31 | 2020 | |
| Biohorizons Implant Systems INC. | $25.03 | 2019 | |
| Straumann USA LLC | $24.35 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Zoccolillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.